 |
 |

VIGNETTES
Sentinel Lymph Node Biopsy for High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Although infrequent, metastases from primary cutaneous squamous cell carcinoma (SCC) do occur, with reported rates ranging from 0.3% to 16%.1-3 Parotid nodes, followed by cervical nodes, are commonly the initial site of metastasis arising from primary SCC of the head and neck. Once lymphatic spread occurs, the prognosis is poor with an overall survival rate of 34.4%.3
In an attempt to improve prognosis, the dermatologist or head and neck surgeon faces the challenge of early identification of affected lymph nodes, ideally before it is clinically or radiologically evident. However, the management of the clinically negative lymphatic basin (N0) is controversial, with opinions ranging from a "watchful waiting" policy to parotidectomy and/or neck dissection with or without radiation therapy.
We tried to evaluate the sentinel node technique as an intermediate approach in the treatment of these patients. The purpose of our study was to apply the sentinel lymph node (SLN) biopsy . . . [Full Text of this Article]
Keyvan Nouri, MD;
Maria Patricia Rivas, MD;
Felipe Pedroso, BS;
Rita Bhatia, MD;
Francisco Civantos, MD
Correspondence: Dr Nouri, 1475 NW 12th Ave, Second Floor, Suite 2175, Miami, FL 33136 (knouri@med.miami.edu).
|